Subcutaneous administration of amifostine: A promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy.
Open Access
- 1 March 2001
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 12 (3) , 421-422
- https://doi.org/10.1023/a:1011184609963
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Subcutaneous Administration of Amifostine During Fractionated Radiotherapy: A Randomized Phase II StudyJournal of Clinical Oncology, 2000
- American Society of Clinical Oncology Clinical Practice Guidelinesfor the Use of Chemotherapy and Radiotherapy ProtectantsJournal of Clinical Oncology, 1999
- Combined Irinotecan and Oxaliplatin Plus Granulocyte Colony-Stimulating Factor in Patients With Advanced Fluoropyrimidine/Leucovorin-Pretreated Colorectal CancerJournal of Clinical Oncology, 1999
- Oxaliplatin in practiceBritish Journal of Cancer, 1998